| Synonyms: | |
| Status: | Approved (2019) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| ATC: | L01XC41 |
| UNII: | 5384HK7574 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | DNA topoisomerase I inhibitor | FDA |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Breast Neoplasms | 4 | D001943 | ClinicalTrials |
| Breast Neoplasms | 4 | D001943 | ClinicalTrials |
| Neoplasms | 4 | D009369 | ClinicalTrials |
| Osteosarcoma | 2 | D012516 | ClinicalTrials |
| Colorectal Neoplasms | 2 | D015179 | ClinicalTrials |
| Stomach Neoplasms | 2 | D013274 | ClinicalTrials |
| Colorectal Neoplasms | 2 | D015179 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
| Digestive System Neoplasms | 2 | D004067 | ClinicalTrials |
| Neoplasm Metastasis | 1 | D009362 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1826843-81-5 |
| ChEMBL | CHEMBL4297844 |
| FDA SRS | 5384HK7574 |
CONTENTS